Sun Yat-sen University: all 1,681 studies

Page 7 of 17. Open to participants first (610), then studies with results posted, then the rest; newest registration first within each.

• Laparoscopic Surgery VS RFA for Recurrent HCCNot yet recruitingNCT02785380Phase 4
• PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T LymphomaRecruitingNCT02705508Phase 2
• Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)RecruitingNCT02624531Not applicable
• Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal CarcinomaRecruitingNCT02610010Phase 3
• Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis PigmentosaNot yet recruitingNCT02465749Early Phase 1
• Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic LymphomaRecruitingNCT02396043Phase 2
• A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients TreatmentRecruitingNCT01994057
• Myocardial Protection Effect of Simvastatin Undergoing Cardiac SurgeryRecruitingNCT01653223Not applicable
• Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade GliomaRecruitingNCT01649830Phase 3
• The New Serial Treatment of Temporomandibular DisordersRecruitingNCT00932594Not applicable
• Efficacy of Two Sonic Toothbrushes in Reducing Extrinsic Tooth StainCompletedNCT05202093Not applicableResults posted
• Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular CarcinomaCompletedNCT04945720Phase 2Results posted
• Whitening Efficacy of Dentifrice Containing 10% High Cleaning Silica, 0.5% Sodium Phytate and 0.5% Sodium PyrophosphateCompletedNCT04238429Not applicableResults posted
• CAR-T Cell Immunotherapy for Advanced Lung CancerTerminatedNCT03330834Phase 1Results posted
• Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast CancerCompletedNCT03045653Phase 2Results posted
• CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular RetinoblastomaCompletedNCT02319486Phase 4Results posted
• Efficacy of a Commercial Dentifrice Containing Ilex Rotunda Thunb Extract for Dental Plaque and GingivitisCompletedNCT02313558Not applicableResults posted
• Icotinib for Completed Resected IB NSCLC With EGFR MutationCompletedNCT02264210Phase 2Results posted
• A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus TreatmentCompletedNCT01689350Not applicableResults posted
• Outcomes of 3 Incision-size-dependent Phacoemulsification SystemsCompletedNCT01429532Results posted
• Instant and Lasting Relief Effects of Strontium Chloride/Potassium Nitrate Dentifrice on Dentin HypersensitivityCompletedNCT01426360Not applicableResults posted
• Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung CancerStatus unknownNCT01218594Phase 2Results posted
• Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung CancerCompletedNCT01194453Phase 2Results posted
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01147627Not applicableResults posted
• Guangdong Uptake of Surgery TrialCompletedNCT01123928Not applicableResults posted
• The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and LipidsCompletedNCT00951912Not applicableResults posted
• A Controlled Study of Uric Acid on the Progression of IgA NephropathyCompletedNCT00793585Not applicableResults posted
• Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With ChemoradiotherapyCompletedNCT00700440Phase 2Results posted
• To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal CancerCompletedNCT00697619Phase 2Results posted
• IC ECG Combined With Ultrasound Bubble Test for PICC Tip Positioning Among Oncology Adults: A Three Arm Randomized Controlled TrialCompletedNCT07888400Not applicable
• Benmelstobart Plus Anlotinib Versus Sunitinib as First-Line Treatment for Advanced Non-Clear Cell Renal Cell CarcinomaActive, not recruitingNCT07881900Phase 3
• Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal InsufficiencyWithdrawnNCT07786571Not applicable
• Guangzhou Preterm and Term Birth Cohort StudyActive, not recruitingNCT07756177
• A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal CancerCompletedNCT07581236Not applicable
• Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCLActive, not recruitingNCT07538180Phase 2
• Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line TreatmentCompletedNCT07537985Not applicable
• Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell CarcinomaActive, not recruitingNCT07488533Phase 2
• Pelvic Floor Peritoneal Closure to Prevent Postoperative Ileus in Mid-Low Rectal Cancer SurgeryActive, not recruitingNCT07432542Not applicable
• Comparison of Nutrient Content Between Preterm and Term Human Milk: a Systematic Review and Meta-analysisCompletedNCT07399405
• Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative TrialActive, not recruitingNCT07380633Phase 2
• Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT07374003Phase 2
• Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC PatientsCompletedNCT07320950Phase 3
• A Virtual Peer Agent for Counseling Adolescents With Stressful Life EventsCompletedNCT07305064Not applicable
• HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICCCompletedNCT07304388Phase 2
• The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective StudyCompletedNCT07272265Not applicable
• Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.Active, not recruitingNCT07201337Phase 3
• AI Multitask Model for HCC TreatmentCompletedNCT07157085
• A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular CarcinomaActive, not recruitingNCT07138885Phase 2
• Artificial Intelligence Diagnosis of Different Histopathological Growth Patterns of Colorectal Cancer Liver MetastasisActive, not recruitingNCT07088393
• Validation of Insulin Dose Prediction Model Based on Artificial Intelligence AlgorithmTerminatedNCT07066891Not applicable
• Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer PatientsCompletedNCT07052734
• Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal CancerCompletedNCT07012174
• Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 DiabetesActive, not recruitingNCT07003191
• Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant ImmunotherapyCompletedNCT06980350
• The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General AnesthesiaWithdrawnNCT06967064Phase 4
• The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate CancerCompletedNCT06915714
• Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-WithdrawnNCT06895577Phase 2
• Osteosclerotic Changes on CT Predict Survival in Prostate CancerCompletedNCT06883474
• Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: an MRI StudyActive, not recruitingNCT06881225
• Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma.Active, not recruitingNCT06854510Phase 2/3
• Local Triamcinolone Injection Combined with Fibrin Glue Spray in Preventing Esophageal Stricture After Big-range Endoscopic Submucosal Dissection for Esophageal Early CancerCompletedNCT06840561Phase 2
• High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal MetastasisCompletedNCT06812871Phase 2
• Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal CancerCompletedNCT06717763
• Comparison of General Anesthesia Hemodynamics Between R and P in Patients Undergoing Laparoscopic HepatectomyCompletedNCT06714669Phase 3
• Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT06712888Phase 3
• the Real-world Data of Risk Factor and Its Prognosis in PREmature Coronary ARtery DIseAse StudyActive, not recruitingNCT06695182
• A Clinical Trial of Esophagectomy for Esophageal CarcinomaCompletedNCT06691503Phase 2
• Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT06673693Phase 2
• TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT06664983Phase 3
• Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)Active, not recruitingNCT06647732Phase 2
• Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT06630780Not applicable
• Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane AnesthesiaCompletedNCT06624696Phase 4
• Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)Active, not recruitingNCT06618014Phase 2
• A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal CancerCompletedNCT06608537Phase 2
• Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)Active, not recruitingNCT06577792Not applicable
• Adaptive Therapy for Post-Second-Line Advanced Breast CancerCompletedNCT06533722Phase 2
• Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular CarcinomaActive, not recruitingNCT06524466Phase 2
• Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)Active, not recruitingNCT06524427Not applicable
• Prognostic Significance of the Uncertain Resection in NSCLCActive, not recruitingNCT06511661
• The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal TherapyStatus unknownNCT06505278Phase 2
• Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCCCompletedNCT06435013
• TIP Regimen Combined With Toripalimab Neoadjuvant Therapy for Locally Advanced Penile CancerCompletedNCT06415318Phase 2
• Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer PatientsCompletedNCT06373744
• Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal CarcinomaCompletedNCT06367049
• Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective StudyActive, not recruitingNCT06347614
• Dyadic Intervention for Psychological Distress of Patients With Colorectal Cancer and Their SpousesCompletedNCT06326437Not applicable
• Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease PatientsCompletedNCT06303089
• Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy EffectivenessCompletedNCT06292052
• Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the EsophagusCompletedNCT06291753
• Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT06281886Phase 2
• Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.Active, not recruitingNCT06277388
• The Effects of a Large Language Model on Clinical Questioning SkillsCompletedNCT06229379Not applicable
• Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA).WithdrawnNCT06227897Phase 2
• Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular CarcinomaCompletedNCT06199297
• Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)Active, not recruitingNCT06143748Phase 2
• Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer RecurrenceActive, not recruitingNCT06143644
• The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLCCompletedNCT06139419Phase 2
• Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCCCompletedNCT06138496Phase 2
• Clinical Significance of Marginal Acute Inflammation for Stage II Colon CancerCompletedNCT06135558
• Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell CarcinomaCompletedNCT06111560

← Sun Yat-sen University overview and focus areas